Citation Impact
Citing Papers
Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells
2013
Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
2013
Regulated Expression of a Tumor-Associated Antigen Reveals Multiple Levels of T-Cell Tolerance in a Mouse Model of Lung Cancer
2008
Intratumoral CpG-B Promotes Antitumoral Neutrophil, cDC, and T-cell Cooperation without Reprograming Tolerogenic pDC
2018
The Tissue-Engineered Vascular Graft—Past, Present, and Future
2015 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Tumoricidal activity of human dendritic cells
2013
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells
2018
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
mRNA-based dendritic cell vaccines
2014
Myeloid-derived suppressor cells coming of age
2018 Standout
Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer
2018
Establishing the Diagnosis of Lung Cancer
2013 Standout
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells
2012
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
2019
Cancer drug resistance: an evolving paradigm
2013 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity
2018
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Coordinated regulation of myeloid cells by tumours
2012 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Trial watch
2013
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer?
2013
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
2023 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy
2015
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
The ReNAissanCe of mRNA-based cancer therapy
2014
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Dendritic cells in cancer: the role revisited
2017
Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy
2017
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Dendritic-Cell-Based Therapeutic Cancer Vaccines
2013
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
2017
Lymph node involvement influenced by lung adenocarcinoma subtypes in tumor size ≤3 cm disease: A study of 2268 cases
2016
Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells
2013
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients
2014
Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets
2015
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results
2019
Human dendritic cell subsets in vaccination
2013
B Lymphocytes and Cancer: A Love–Hate Relationship
2016
Cancer-related inflammation and treatment effectiveness
2014 Standout
Plasmacytoid dendritic cell in immunity and cancer
2018
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment
2018
A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer
2015
The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
2018
Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models
2021
Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion
2013
Correlation between the Size of the Solid Component on Thin-Section CT and the Invasive Component on Pathology in Small Lung Adenocarcinomas Manifesting as Ground-Glass Nodules
2013
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
2010
Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017
2017 Standout
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
2013
CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
2010
Translational nanoparticle engineering for cancer vaccines
2017
Dendritic Cell–Based Immunotherapy: State of the Art and Beyond
2016
Immunology of Plasmacytoid Dendritic Cells in Solid Tumors: A Brief Review
2019
Dendritic Cell–Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
2015
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets
2016
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
2015 StandoutNobel
The B-Side of Cancer Immunity: The Underrated Tune
2019
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma
2011
Works of Tetsuro Baba being referenced
Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
2013
Association between lymphangiogenesis-/micrometastasis- and adhesion-related molecules in resected stage I NSCLC
2010
Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan
2008
Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro
2007
Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer
2009
Limited pulmonary resection for peripheral small-sized adenocarcinoma of the lung
2010
Prognostic implications of human leukocyte antigen class I expression in patients who underwent surgical resection for non–small-cell lung cancer
2012
Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B
2007
Immunosuppressive effect of regulatory T lymphocytes in lung cancer, with special reference to their effects on the induction of autologous tumor-specific cytotoxic T lymphocytes
2012
Effect of IgG produced by tumor-infiltrating B lymphocytes on lung tumor growth.
2006
Antitumor Effect of Antibody against a SEREX-Defined Antigen (UOEH-LC-1) on Lung Cancer Xenotransplanted into Severe Combined Immunodeficiency Mice
2007
A Study of Surgically Resected Peripheral Non-Small Cell Lung Cancer with a Tumor Diameter of 1.0 CM or Less
2011